Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-18 Sale |
2022-04-20 4:23 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $11.04 | $55,200 | 0 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-04 4:32 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
7,600 | $16.2 | $123,120 | 136,400 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-14 4:21 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Chief Medical Officer |
161,139 | $16.88 | $2,719,493 | 37,954 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 4:24 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
20,000 | $17.16 | $343,200 | 230,056 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 5:04 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $17.2 | $39,560 | 11,198 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-16 4:25 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $18.5 | $92,500 | 5,000 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:45 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
184,000 | $15.04 | $2,767,360 | 911,602 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 4:38 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
30,100 | $12.2 | $367,220 | 215,056 (Direct) |
View |
| 2021-11-24 Purchase |
2021-11-24 6:35 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
7,500 | $12.19 | $91,425 | 17,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-07 Option Award |
2022-06-09 4:45 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
42,888 | $0 | 60,251 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:43 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
42,888 | $0 | 42,888 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:41 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
42,888 | $0 | 46,085 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:40 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEE KENNETH B JR Director |
42,888 | $0 | 67,140 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:38 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director |
42,888 | $0 | 42,888 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:36 pm |
2023-06-07 2032-06-07 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
42,888 | $0 | 76,616 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:43 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
569 | $9.31 | 33,728 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
1,138 | $9.31 | 17,363 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:37 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
1,138 | $9.31 | 3,197 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:34 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director |
2,078 | $9.31 | 82,138 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 4:23 pm |
N/A 2022-05-23 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $0 | 0 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 4:23 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $3.32 | 0 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 4:21 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Chief Medical Officer |
148,302 | $3.22 | 37,954 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 4:21 pm |
2017-05-23 2026-05-23 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Chief Medical Officer |
148,302 | $0 | 37,954 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:04 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $4.73 | 11,198 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:04 pm |
2013-03-01 2022-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $0 | 11,198 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:43 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
602 | $16.61 | 2,059 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director |
1,128 | $16.61 | 80,060 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
602 | $16.61 | 16,225 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:34 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
301 | $16.61 | 33,159 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-16 4:25 pm |
N/A 2022-05-23 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-16 4:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
5,000 | $3.32 | 5,000 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 5:06 pm |
N/A 2032-02-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director |
26,667 | $0 | 26,667 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-13 4:45 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
184,000 | $4.73 | 911,602 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-13 4:45 pm |
2013-03-01 2022-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
184,000 | $0 | 911,602 (Direct) |
View |
| 2021-12-14 Option Award(A) |
2022-01-13 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
75,000 | $0 | 168,719 (Direct) |
View |
| 2021-12-14 Option Award(A) |
2022-01-13 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
80,000 | $0 | 216,556 (Direct) |
View |
| 2021-12-14 Option Award(A) |
2022-01-13 4:36 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
55,000 | $0 | 201,969 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:16 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
17,550 | $0 | 22,898 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:12 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
289,000 | $0 | 425,556 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:09 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
199,000 | $0 | 414,056 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:06 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
249,000 | $0 | 349,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:03 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
239,000 | $0 | 385,969 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:59 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
279,000 | $0 | 372,719 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:56 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Chief Medical Officer |
199,000 | $0 | 214,791 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:53 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
697,500 | $0 | 1,481,102 (Direct) |
View |
| 2021-09-01 Gift |
2021-12-16 4:53 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
5,000 | $0 | 1,481,102 (Direct) |
View |
| 2021-12-07 Exercise |
2021-12-09 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
62,000 | $4.73 | 215,056 (Direct) |
View |
| 2021-12-07 Exercise |
2021-12-09 4:38 pm |
2013-03-01 2022-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
62,000 | $0 | 215,056 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:15 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
414 | $12.06 | 32,858 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:13 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
829 | $12.06 | 1,457 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:10 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
829 | $12.06 | 15,623 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:08 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director |
1,554 | $12.06 | 78,932 (Direct) |
View |